×
Hero Background

Clonorchiasis Companies

ID: MRFR/Pharma/3265-HCR
110 Pages
Rahul Gotadki
October 2025

Clonorchiasis is a parasitic infection caused by the liver fluke Clonorchis sinensis. The infection is typically acquired by consuming raw or undercooked freshwater fish that harbor the infective stage of the parasite. While there are no specific companies solely dedicated to clonorchiasis, pharmaceutical companies, research institutions, and health organizations may be involved in the development of diagnostic tools, treatments, and prevention strategies for parasitic infections, including clonorchiasis.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Clonorchiasis Market Research Report-Forecast Till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Clonorchiasis Market

Clonorchiasis Key Companies

 

Latest Clonorchiasis Companies Update


Merck and Johnson & Johnson contribute to public health initiatives in endemic regions, improving access to basic healthcare and sanitation infrastructure.


World Health Organization (WHO) and the Bill & Melinda Gates Foundation are actively involved in funding research, promoting control programs, and raising awareness about Clonorchiasis.


List of Clonorchiasis Key Companies in the Market



  • Pfizer (U.S)

  • Bayer AG (Germany)

  • Provet (Switzerland)

  • Virbac (India)

  • Cipla (India)

  • Novartis AG (Switzerland)

  • CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India)

  • Merck & Co. Inc. (U.S.)

  • Hoffmann-La Roche Ltd. (Switzerland)

  • Abbott (U.S.)

  • Arsanis Inc. (Austria)

  • Novabiotics (U.K.)

  • GlaxoSmithKline plc. (U.K.)

  • Teva Pharmaceutical Industries Ltd (Taiwan)